Qing‐Lei Zeng

机构：First Affiliated Hospital of Zhengzhou University · ORCID：0000-0002-2094-4784

发表论文 104 篇 · 总被引 1501 次 · h-index 20

代表论文

• A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease (2024 · Hepatology International · 被引 33)
• acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study (2024 · Clinical Gastroenterology and Hepatology · 被引 17)
• Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306) (2024 · Clinical and Molecular Hepatology · 被引 9)
• “Fatty” or “steatotic”: Position statement from a linguistic perspective by the Chinese-speaking community (2024 · Journal of Hepatology · 被引 9)
• Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China (2024 · BMJ Open · 被引 7)
• GNLY+CD8+ T cells bridge premature aging and persistent inflammation in people living with HIV (2025 · Emerging Microbes & Infections · 被引 6)